Corporate Profile

Neos Therapeutics is focused on developing, manufacturing and commercializing branded products utilizing our proprietary extended-release drug delivery technology platform. We have used this technology to develop our three product candidates being investigated for the treatment of attention deficit hyperactivity disorder, or ADHD. Our ADHD product candidates are extended-release, or XR, medications in patient-friendly, orally disintegrating tablets, or ODT, or liquid suspension dosage forms.

News Releases